This was confirmed by flow cytometry using the marker ALDH1 that has previously been shown to enrich HER2-positive breast cancer cell populations for tumour initiating cells (Additional file 1 Figure S7) [48]. The gene discussed is ERBB2; the disease is neoplasm.